• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型gp120 V5环上的N463糖基化位点调节HIV-1对中和性单克隆抗体VRC01/03的敏感性。

N463 Glycosylation Site on V5 Loop of a Mutant gp120 Regulates the Sensitivity of HIV-1 to Neutralizing Monoclonal Antibodies VRC01/03.

作者信息

Wang Wenbo, Zirkle Brett, Nie Jianhui, Ma Jian, Gao Kai, Chen Xiaojiang S, Huang Weijing, Kong Wei, Wang Youchun

机构信息

*College of Life Science, Jilin University, Changchun, China; †Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Division of Monoclonal Antibody, National Institutes for Food and Drug Control (NIFDC), Beijing, China; ‡Department of Molecular and Computational Biology/Chemistry Department/Norris Cancer Center, University of Southern California, Los Angeles, CA; and §Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC), Beijing, China.

出版信息

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):270-7. doi: 10.1097/QAI.0000000000000595.

DOI:10.1097/QAI.0000000000000595
PMID:25751231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4506726/
Abstract

BACKGROUND

HIV-1 gp120/gp41 is heavily modified by n-linked carbohydrates that play important roles either in correct folding or in shielding vulnerable viral protein surfaces from antibody recognition.

METHODS

In our previous work, 25 potential N-linked glycosylation sites (PNGS) of a CRF07_BC isolate of HIV-1 were individually mutated, and the resulting effects on infectivity and antibody-mediated neutralization were evaluated. To further understand the functional role of these PNGS, we generated double and multiple mutants from selected individual PNGS mutants. The effects were then evaluated by examining infectivity and sensitivity to antibody-mediated neutralization by neutralizing monoclonal antibodies (nMAbs) and serum antibodies from HIV-1 positive donors.

RESULTS

Infectivity results showed that, among the 12 combined PNGS mutants, only 197M.1 (N197D/N301Q) lost infectivity completely, whereas all others (except for 197M.6) showed reduced viral infectivity. In terms of neutralization sensitivity to known nMAbs, we found that adding N463Q mutation to all the gp120 mutants containing N197D significantly increased neutralization sensitivity to VRC01 and VRC03, suggesting N197 and N463 have a strong synergistic effect in regulating the neutralizing sensitivity of HIV-1 to the anti-CD4bs nMAbs VRC01/VRC03. Structural analysis based on the available structures of gp120 alone and in complex with CD4 and various nMAbs elucidates a molecular rationale for this experimental observation.

CONCLUSIONS

The data indicate that N463 plays an important role in regulating the CD4bs MAbs VRC01/VRC03 sensitivity in the genetic background of N197D mutation of gp120, which should provide valuable information for a better understanding of the interplay between HIV-1 and VRC01/03.

摘要

背景

HIV-1 gp120/gp41被N-连接碳水化合物大量修饰,这些碳水化合物在正确折叠或保护易受攻击的病毒蛋白表面不被抗体识别方面发挥重要作用。

方法

在我们之前的工作中,对一株HIV-1 CRF07_BC分离株的25个潜在N-连接糖基化位点(PNGS)进行了单独突变,并评估了其对感染性和抗体介导中和作用的影响。为了进一步了解这些PNGS的功能作用,我们从选定的单个PNGS突变体中构建了双突变体和多突变体。然后通过检测感染性以及对来自HIV-1阳性供体的中和单克隆抗体(nMAbs)和血清抗体介导的中和作用的敏感性来评估其效果。

结果

感染性结果显示,在12个组合的PNGS突变体中,只有197M.1(N197D/N301Q)完全丧失感染性,而其他所有突变体(除197M.6外)的病毒感染性均降低。在对已知nMAbs的中和敏感性方面,我们发现,在所有含有N197D的gp120突变体中添加N463Q突变显著增加了对VRC01和VRC03的中和敏感性,表明N197和N463在调节HIV-1对抗CD4bs nMAbs VRC01/VRC03的中和敏感性方面具有很强的协同作用。基于单独的gp120以及与CD4和各种nMAbs复合物的现有结构进行的结构分析阐明了这一实验观察结果的分子原理。

结论

数据表明,在gp120的N197D突变的遗传背景下,N463在调节CD4bs单克隆抗体VRC01/VRC03敏感性方面发挥重要作用,这应为更好地理解HIV-1与VRC01/03之间的相互作用提供有价值的信息。

相似文献

1
N463 Glycosylation Site on V5 Loop of a Mutant gp120 Regulates the Sensitivity of HIV-1 to Neutralizing Monoclonal Antibodies VRC01/03.突变型gp120 V5环上的N463糖基化位点调节HIV-1对中和性单克隆抗体VRC01/03的敏感性。
J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):270-7. doi: 10.1097/QAI.0000000000000595.
2
A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization.HIV-1 包膜蛋白糖基化位点对感染性和抗体介导中和作用的系统研究。
Retrovirology. 2013 Feb 6;10:14. doi: 10.1186/1742-4690-10-14.
3
Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.广谱中和 HIV-1 单克隆抗体 VRC01 的中和机制。
J Virol. 2011 Sep;85(17):8954-67. doi: 10.1128/JVI.00754-11. Epub 2011 Jun 29.
4
A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1.一种针对 gp120 的 CD4 结合位点的人源抗体,能够高度有效地但偶尔地交叉中和原发性 HIV-1。
PLoS One. 2013 Aug 26;8(8):e72054. doi: 10.1371/journal.pone.0072054. eCollection 2013.
5
A single residue within the V5 region of HIV-1 envelope facilitates viral escape from the broadly neutralizing monoclonal antibody VRC01.HIV-1 包膜 V5 区的单个残基有助于病毒逃避广泛中和单克隆抗体 VRC01 的攻击。
J Biol Chem. 2012 Dec 14;287(51):43170-9. doi: 10.1074/jbc.M112.399402. Epub 2012 Oct 25.
6
Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site.广谱中和抗体对 HIV-1 包膜的选择压力作用于保守的 CD4 结合位点。
J Virol. 2012 May;86(10):5844-56. doi: 10.1128/JVI.07139-11. Epub 2012 Mar 14.
7
Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.HIV-1包膜亚基蛋白gp120核心的糖基化对于天然三聚体的形成或病毒感染性并非必需。
J Biol Chem. 2017 Jun 16;292(24):10197-10219. doi: 10.1074/jbc.M117.788919. Epub 2017 Apr 26.
8
Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.一种通过病毒逃逸导致膜近端外部区域(MPER)暴露的新型HIV-1 gp120-gp41界面抗体的结构与识别
PLoS Pathog. 2017 Jan 11;13(1):e1006074. doi: 10.1371/journal.ppat.1006074. eCollection 2017 Jan.
9
PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4.PGV04 是一种 HIV-1 gp120 CD4 结合位点抗体,具有广谱和高效的中和作用,但不会诱导 CD4 特征性的构象变化。
J Virol. 2012 Apr;86(8):4394-403. doi: 10.1128/JVI.06973-11. Epub 2012 Feb 15.
10
Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.人类免疫缺陷病毒 1 型 CRF01_AE 包膜糖蛋白 gp120 的 V2 和 C2 区氨基酸取代对广泛中和抗体针对 CD4 结合位点的病毒中和敏感性的影响。
Retrovirology. 2014 Apr 23;11:32. doi: 10.1186/1742-4690-11-32.

引用本文的文献

1
Self-reported neurocognitive complaints in the Swiss HIV Cohort Study: a viral genome-wide association study.瑞士HIV队列研究中的自我报告神经认知主诉:一项病毒全基因组关联研究
Brain Commun. 2024 May 31;6(4):fcae188. doi: 10.1093/braincomms/fcae188. eCollection 2024.
2
Pseudotyped Viruses for Lyssavirus.用于狂犬病病毒的假型病毒
Adv Exp Med Biol. 2023;1407:191-208. doi: 10.1007/978-981-99-0113-5_10.
3
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的突变:对免疫逃逸和疫苗诱导免疫的影响。
Semin Immunol. 2021 Jun;55:101533. doi: 10.1016/j.smim.2021.101533. Epub 2021 Nov 20.
4
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.SARS-CoV-2 从高中和性的 COVID-19 恢复期血浆中逃逸。
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36). doi: 10.1073/pnas.2103154118.
5
Lentil lectin derived from exhibit broad antiviral activities against SARS-CoV-2 variants.豌豆凝集素来源于 ,对 SARS-CoV-2 变体表现出广泛的抗病毒活性。
Emerg Microbes Infect. 2021 Dec;10(1):1519-1529. doi: 10.1080/22221751.2021.1957720.
6
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对一种高度中和的新型冠状病毒肺炎康复期血浆产生逃逸。
bioRxiv. 2020 Dec 28:2020.12.28.424451. doi: 10.1101/2020.12.28.424451.
7
Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infection.潜伏储库中预先存在的耐药性可能会影响慢性 HIV-1 感染期间的 VRC01 治疗效果。
PLoS Comput Biol. 2020 Nov 30;16(11):e1008434. doi: 10.1371/journal.pcbi.1008434. eCollection 2020 Nov.
8
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.SARS-CoV-2 刺突突变对病毒感染力和抗原性的影响。
Cell. 2020 Sep 3;182(5):1284-1294.e9. doi: 10.1016/j.cell.2020.07.012. Epub 2020 Jul 17.
9
HIV-1 pseudoviruses constructed in China regulatory laboratory.中国监管实验室构建的 HIV-1 假病毒。
Emerg Microbes Infect. 2019 Dec 20;9(1):32-41. doi: 10.1080/22221751.2019.1702479. eCollection 2020.
10
Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity.一名具有广泛中和活性的中国慢性HIV-1感染患者包膜基因的特征
Front Microbiol. 2019 May 24;10:1096. doi: 10.3389/fmicb.2019.01096. eCollection 2019.

本文引用的文献

1
Crystal structure of a soluble cleaved HIV-1 envelope trimer.可溶性 HIV-1 包膜三聚体的晶体结构
Science. 2013 Dec 20;342(6165):1477-83. doi: 10.1126/science.1245625. Epub 2013 Oct 31.
2
A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization.HIV-1 包膜蛋白糖基化位点对感染性和抗体介导中和作用的系统研究。
Retrovirology. 2013 Feb 6;10:14. doi: 10.1186/1742-4690-10-14.
3
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.强效广谱中和 HIV 抗体对复合型 N-聚糖的识别。
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):E3268-77. doi: 10.1073/pnas.1217207109. Epub 2012 Oct 30.
4
A single residue within the V5 region of HIV-1 envelope facilitates viral escape from the broadly neutralizing monoclonal antibody VRC01.HIV-1 包膜 V5 区的单个残基有助于病毒逃避广泛中和单克隆抗体 VRC01 的攻击。
J Biol Chem. 2012 Dec 14;287(51):43170-9. doi: 10.1074/jbc.M112.399402. Epub 2012 Oct 25.
5
Structural mechanism of trimeric HIV-1 envelope glycoprotein activation.三聚体 HIV-1 包膜糖蛋白激活的结构机制。
PLoS Pathog. 2012;8(7):e1002797. doi: 10.1371/journal.ppat.1002797. Epub 2012 Jul 12.
6
PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4.PGV04 是一种 HIV-1 gp120 CD4 结合位点抗体,具有广谱和高效的中和作用,但不会诱导 CD4 特征性的构象变化。
J Virol. 2012 Apr;86(8):4394-403. doi: 10.1128/JVI.06973-11. Epub 2012 Feb 15.
7
The W100 pocket on HIV-1 gp120 penetrated by b12 is not a target for other CD4bs monoclonal antibodies.b12 穿透 HIV-1 gp120 的 W100 口袋不是其他 CD4bs 单克隆抗体的靶标。
Retrovirology. 2012 Jan 27;9:9. doi: 10.1186/1742-4690-9-9.
8
Highly conserved HIV-1 gp120 glycans proximal to CD4-binding region affect viral infectivity and neutralizing antibody induction.高度保守的 HIV-1 gp120 糖基位于 CD4 结合区附近,影响病毒感染力和中和抗体的诱导。
Virology. 2012 Feb 5;423(1):97-106. doi: 10.1016/j.virol.2011.11.023. Epub 2011 Dec 20.
9
High-mannose glycan-dependent epitopes are frequently targeted in broad neutralizing antibody responses during human immunodeficiency virus type 1 infection.高甘露糖依赖性表位在人类免疫缺陷病毒 1 型感染期间经常成为广谱中和抗体反应的靶标。
J Virol. 2012 Feb;86(4):2153-64. doi: 10.1128/JVI.06201-11. Epub 2011 Dec 7.
10
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.HIV-1 gp120 V1/V2 结构域与广谱中和抗体 PG9 结合。
Nature. 2011 Nov 23;480(7377):336-43. doi: 10.1038/nature10696.